CYNTHIA GALBRAITH: Open Payments
NPI 1205106747 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Mayne Pharma Commercial LLC | 1 | $114 |
| Novo Nordisk Inc | 3 | $52 |
| PFIZER INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 2 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: BIJUVA, Rybelsus, Cologuard Collection Kit, NEFFY, GARDASIL 9, PREVNAR 20, GEMTESA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
